Coronavac/Sinovac | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

170 results for “Coronavac/Sinovac”

Trials

View all 79 →

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

1,290 participants · First posted Jun 28, 2021

Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent

1 participants · First posted Feb 9, 2022

Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

150 participants · First posted Nov 5, 2009

Drugs

View all 56 →

Investigational

CoronaVac

Pneumococcal 23-valent vaccine (Sinovac Biotech)

trivalent COVID-19 Vaccine (Sinovac Biotech)

Organizations

View all 20 →

Sinovac Biotech Ltd.

China

Sinovac Biotech Co., Ltd.

China

Sinovac Biotech (Hong Kong) Limited

Hong Kong, China

News

View all 15 →

WHO-Supported Study Reveals COVID-19 Vaccine Effectiveness Among Egyptian Healthcare Workers During Omicron Era

Global Study Links COVID-19 Infection and Adenoviral Vaccines to Guillain-Barré Syndrome Risk, Clears mRNA Vaccines

Sinovac Launches Phase III Trial of Bivalent HFMD Vaccine

Page 1 of 17